Biphenyl

Biphenyl

SCHEMBL2494151

CC(C)[C@H](N)C(=O)O.c1ccc(-c2ccccc2)cc1

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 1/20 0.65
PTGS2 P35354 1/20 0.53
TAAR1 Q96RJ0 1/20 0.50
CYP1A2 P05177 1/20 0.48
GAA P10253 1/20 0.48
CYP2C9 P11712 1/20 0.48
PKM P14618 1/20 0.48
CYP2C19 P33261 1/20 0.48
SLC1A3 P43003 2/20 0.47
SLC1A2 P43004 2/20 0.47
SLC1A1 P43005 2/20 0.47
ADAMTS4 O75173 3/20 0.45
MMP2 P08253 2/20 0.45
MMP3 P08254 2/20 0.45
MMP13 P45452 2/20 0.45
MMP1 P03956 1/20 0.45
MMP7 P09237 1/20 0.45
MMP9 P14780 1/20 0.45
PDCD1 Q15116 1/20 0.44
CD274 Q9NZQ7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biphenyl SCHEMBL27824248 1.00 SLC7A5 (0.65) SLC7A5PTGS2TAAR1CYP1A2GAA
Valine SCHEMBL2587287 0.91 SLC7A5 (0.71) SLC7A5PTGS2TAAR1CYP1A2GAA
Biphenyl SCHEMBL2489290 0.88 SLC7A5 (0.50) SLC7A5PTGS2TAAR1CYP1A2GAA
Valine SCHEMBL4582565 0.86 SLC7A5 (0.88) SLC7A5CYP1A2CYP2C9CYP2C19SLC1A3
Valine SCHEMBL28052598 0.86 SLC7A5 (0.88) SLC7A5CYP1A2CYP2C9CYP2C19SLC1A3
Valine SCHEMBL11524576 0.85 SLC7A5 (0.62) SLC7A5CYP1A2GAACYP2C9PKM
Valine SCHEMBL754999 0.85 SLC7A5 (0.62) SLC7A5CYP1A2CYP2C9CYP2C19SLC1A3
Valine SCHEMBL5479272 0.85 SLC7A5 (0.62) SLC7A5CYP1A2CYP2C9CYP2C19SLC1A3
Valine SCHEMBL3709487 0.85 SLC7A5 (0.62) SLC7A5CYP1A2CYP2C9CYP2C19SLC1A3
Valine SCHEMBL6639200 0.85 SLC7A5 (0.62) SLC7A5PTGS2CYP1A2CYP2C9PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102329306-A Biphenyl valine derivative and application thereof in preparation of medicine for prevention and/or treatment of hypertension SUZHOU BORUI BIOLOG PHARMACEUTICAL TECHNOLOGY CO LTD 2012-01-25 CN claimed
US-8481327-B2 Methods for using congeneric, chlorinated, brominated and/or iodised, fluorinated aromatic standard compounds having two benzol rings CHIRON AS (NO) 2013-07-09 US disclosed
CN-102329306-A Biphenyl valine derivative and application thereof in preparation of medicine for prevention and/or treatment of hypertension SUZHOU BORUI BIOLOG PHARMACEUTICAL TECHNOLOGY CO LTD 2012-01-25 CN disclosed
CN-102329306-A Biphenyl valine derivative and application thereof in preparation of medicine for prevention and/or treatment of hypertension SUZHOU BORUI BIOLOG PHARMACEUTICAL TECHNOLOGY CO LTD 2012-01-25 CN disclosed
CN-102329306-A Biphenyl valine derivative and application thereof in preparation of medicine for prevention and/or treatment of hypertension SUZHOU BORUI BIOLOG PHARMACEUTICAL TECHNOLOGY CO LTD 2012-01-25 CN disclosed
US-20110229973-A1 CONGENERIC, CHLORINATED, BROMINATED AND/OR IODISED, FLUORINATED AROMATIC COMPOUNDS COMPRISING TWO BENZOL RINGS IN THEIR BASIC STRUCTURE, METHOD FOR THEIR PRODUCTION AND USE THEREOF CHIRON AS (NO) 2011-09-22 US disclosed
US-20070298501-A1 Congeneric, Chlorinated, Brominated And/Or Iodised, Fluorinated Aromatic Compounds Comprising Two Benzol Rings In Their Basic Structure, Method For Their Production And Use Thereof CHIRON AS (NO) 2007-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070298501-A1 Congeneric, Chlorinated, Brominated And/Or Iodised, Fluorinated Aromatic Compounds Comprising Two Benzol Rings In Their Basic Structure, Method For Their Production And Use Thereof CBR1, CYP1A1, CYP1B1 SLC7A5 2323/4885PTGS2 4308/4885TAAR1 863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.